title: [Management of myocardial infarction in Spain (1995-99). Data from the registry of the Ischaemic Heart Disease Working Group (RISCI) of the Spanish Society of Cardiology].
abstract: OBJECTIVE
  Limited information is available on how patients with myocardial infarction are treated in Spain. In order to make up for this deficiency, in October 1994, the Ischaemic Heart Disease Working Group of the Spanish Society of Cardiology initiated a myocardial infarction registry, which is currently active.
  
  
  METHODS
  Patients are recruited from hospitals with intensive coronary care facilities. Demographic characteristics coronary risk factors and previous conditions are collected, as well as clinical events, and diagnostic and therapeutic procedures performed during the stay in the coronary care unit.
  
  
  RESULTS
  From 1995 to 1999, 28,357 patients were registered. During this period the mean age increased slightly (from 64.4 +/- 12.2 to 65.2 +/- 12.7; p < 0.001), although the male proportion remained stable (from 76.7% to 77.1%). The median "onset of symptoms-hospital arrival for 1st emergency" time fell from 135 min to 120 min, and the median "onset of symptoms-needle" time from 180 to 175 (NS). The use of thrombolytic therapy did not change (from 42.4 to 43.9%), but the use of aspirin (from 87.4 to 91.7%), beta-blockers (from 32.7 to 39.6%) and angiotensin-converting inhibitors (from 27.9 to 34.8%) increased significantly (p < 0.001). The Swan-Ganz catheter and the intra-aortic balloon counterpulsation were rarely placed during the five years (4.2% and 1.2% respectively in 1999). Both early mortality (11.4 to 9.3%) and the median duration of intensive coronary care stay declined, in these 5 years.
  
  
  CONCLUSIONS
  In Spain, during the 1995-1999 period, the use of aspirin, beta-blockers, and angiotensin-converting inhibitors increased significantly during the acute phase of infarction in the coronary care unit. However, both the usage of thrombolytic therapy and the delay between the onset of symptoms and therapy initiation remained unchanged. At the same time, the length of stay in the coronary care unit and early mortality declined, although the clinical profile of the patients did not improve.
authors.affiliation: Hospital Txagorritxu, Vitoria-Gasteiz, Spain. aros.borau@jet.es
authors.forename: F
authors.initials: F
authors.lastname: Arós
authors.forename: A
authors.initials: A
authors.lastname: Loma-Osorio
authors.forename: X
authors.initials: X
authors.lastname: Bosch
authors.forename: J
authors.initials: J
authors.lastname: González Aracil
authors.forename: L
authors.initials: L
authors.lastname: López Bescós
authors.forename: J
authors.initials: J
authors.lastname: Marrugat
authors.forename: P
authors.initials: P
authors.lastname: Pabón
authors.forename: M
authors.initials: M
authors.lastname: Palencia
authors.forename: F
authors.initials: F
authors.lastname: Worner
mesh_terms: D000368:Aged; D003325:Coronary Care Units / Q000706:statistics & numerical data; D003625:Data Collection / Q000379:methods; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D017052:Hospital Mortality / Q000639:trends; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D012042:Registries / Q000592:standards / Q000706:statistics & numerical data*; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
chemical_list: D005343:Fibrinolytic Agents